Surf Wiki
Save to docs
general/quinolone-antibiotics

From Surf Wiki (app.surf) — the open knowledge base

Garenoxacin

Chemical compound

Chemical compound

| elimination_half-life =

Garenoxacin (INN) is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.

Garenoxacin was discovered by Toyama Chemical Co., Ltd. of Tokyo, Japan, and is currently being marketed in Japan under the tradename Geninax. Schering-Plough holds worldwide rights for garenoxacin, except for Japan, South Korea, and China.

On February 13, 2006, Schering-Plough announced that the United States Food and Drug Administration had accepted the New Drug Application (NDA) for garenoxacin, and had been granted a 10-month review. As of 2015, however, it has not been approved in the US.

Schering-Plough later withdrew its application to the United States Food and Drug Administration, FDA, (August 20, 2006) for approval of the antibiotic Garenoxacin.

The European Medicines Agency (EMA) had also been formally notified by Schering-Plough Europe (July 25, 2007) of its decision to withdraw the application for a centralized marketing authorization for garenoxacin as well. Based on the CHMP review of the data regarding safety and efficacy (risk/benefit), the CHMP considered the application for garenoxacin to be unapprovable.

References

References

  1. (December 2008). "Clinical studies of garenoxacin". International Journal of Antimicrobial Agents.
  2. "Drugs.com, Schering-Plough Reports Garenoxacin NDA Accepted for FDA Review".
  3. (20 August 2006). "Schering-Plough pulls its garenoxacin app".
  4. (28 July 2007). "Schering-Plough Europe Withdraws Its Marketing Authorisation Application For Garenoxacin Mesylate". MediLexicon International Ltd.
  5. (17 September 2018). "Garenoxacin mesylate: Withdrawn application".
  6. "Schering-Plough Europe withdraws its marketing authorisation applicationfor Garenoxacin mesylate".
  7. (18 October 2007). "Withdrawal Assessment report for Garenoxacin Mesylate (garenoxacin)". European Medicines Agency.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

quinolone-antibiotics isoindolines phenol-ethers cyclopropyl-compounds carboxylic-acids
Want to explore this topic further?

Ask Mako anything about Garenoxacin — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report